
Nexus AG – LSE:0FGL.L
Nexus AG stock price today
Nexus AG stock price monthly change
Nexus AG stock price quarterly change
Nexus AG stock price yearly change
Nexus AG key metrics
Market Cap | 1.20B |
Enterprise value | 1.18B |
P/E | 44.27 |
EV/Sales | 4.55 |
EV/EBITDA | 19.97 |
Price/Sales | 4.54 |
Price/Book | 4.45 |
PEG ratio | 0.66 |
EPS | 1.44 |
Revenue | 249.42M |
EBITDA | 54.54M |
Income | 24.93M |
Revenue Q/Q | 14.48% |
Revenue Y/Y | 16.20% |
Profit margin | 10.25% |
Oper. margin | 14.57% |
Gross margin | 37.2% |
EBIT margin | 14.57% |
EBITDA margin | 21.87% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNexus AG stock price history
Nexus AG stock forecast
Nexus AG financial statements
Jun 2023 | 56.82M | 5.17M | 9.1% |
---|---|---|---|
Sep 2023 | 59.42M | 6.73M | 11.33% |
Dec 2023 | 70.19M | 6.46M | 9.21% |
Mar 2024 | 62.98M | 6.57M | 10.43% |
2027 | 330.66M | 51.40M | 15.54% |
---|
Analysts Price target
Financials & Ratios estimates
Payout ratio | 14.19% |
---|
2019 | 0.49% |
---|---|
2020 | 0.35% |
2021 | 0.27% |
2022 | 0.35% |
2023 | 0.36% |
Jun 2023 | 375953000 | 130.77M | 34.78% |
---|---|---|---|
Sep 2023 | 399711000 | 148.11M | 37.05% |
Dec 2023 | 411716000 | 153.13M | 37.19% |
Mar 2024 | 434864000 | 171.01M | 39.33% |
Jun 2023 | 3.01M | -11.95M | -10.28M |
---|---|---|---|
Sep 2023 | 3.68M | 3.89M | -2.98M |
Dec 2023 | 1.26M | 6.04M | -2.25M |
Mar 2024 | 25.54M | -21.07M | -1.55M |
Nexus AG alternative data
Aug 2023 | 1,700 |
---|---|
Sep 2023 | 1,700 |
Oct 2023 | 1,700 |
Nov 2023 | 1,700 |
Dec 2023 | 1,800 |
Jan 2024 | 1,800 |
Feb 2024 | 1,800 |
Mar 2024 | 1,930 |
Apr 2024 | 1,930 |
May 2024 | 1,930 |
Jun 2024 | 1,900 |
Jul 2024 | 1,900 |
Nexus AG other data
Insider | Compensation |
---|---|
Dr. Ingo Behrendt Chairman of the Executive Board & Chief Executive Officer | $906,000 |
Mr. Ralf Heilig M.B.A. Chief Sales Officer & Member of the Executive Board | $274,000 |
Mr. Edgar Kuner Chief Devel. Officer & Member of Executive Board | $259,000 |
-
What's the price of Nexus AG stock today?
One share of Nexus AG stock can currently be purchased for approximately $72.61.
-
When is Nexus AG's next earnings date?
Unfortunately, Nexus AG's (0FGL.L) next earnings date is currently unknown.
-
Does Nexus AG pay dividends?
Yes, Nexus AG pays dividends and its trailing 12-month yield is 0.32% with 14% payout ratio. The last Nexus AG stock dividend of $0.18 was paid on 6 May 2020.
-
How much money does Nexus AG make?
Nexus AG has a market capitalization of 1.20B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 15.46% to 241.46M US dollars.
-
What is Nexus AG's stock symbol?
Nexus AG is traded on the LSE under the ticker symbol "0FGL.L".
-
What is Nexus AG's primary industry?
Company operates in the Healthcare sector and Medical - Equipment & Services industry.
-
How do i buy shares of Nexus AG?
Shares of Nexus AG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Nexus AG's key executives?
Nexus AG's management team includes the following people:
- Dr. Ingo Behrendt Chairman of the Executive Board & Chief Executive Officer()
- Mr. Ralf Heilig M.B.A. Chief Sales Officer & Member of the Executive Board()
- Mr. Edgar Kuner Chief Devel. Officer & Member of Executive Board()
-
How many employees does Nexus AG have?
As Jul 2024, Nexus AG employs 1,900 workers, which is 2% less then previous quarter.
-
When Nexus AG went public?
Nexus AG is publicly traded company for more then 15 years since IPO on 18 Jun 2010.
-
What is Nexus AG's official website?
The official website for Nexus AG is nexus-ag.de.
-
How can i contact Nexus AG?
Nexus AG can be reached via phone at +49 771 229600.
Nexus AG company profile:

Nexus AG
nexus-ag.deLSE
1,980
Medical - Equipment & Services
Healthcare
Nexus AG develops and sells software and hardware solutions, and provides IT services, primarily for customers in the health care system worldwide. It operates in two divisions, Healthcare Software and Healthcare Services. The company offers information systems, such as NEXUS/HIS and KIS for somatic hospitals; NEXUS/PSYCHIATRY for psychiatric institutions; NEXUS/REHAB for rehabilitation facilities; ITR, a software for rehabilitation, clinics, and hotels with medical care; NEXUS/ARCHIVE and PEGASOS, an archiving and process management system; NEXUS/QM for quality management; NEXUS/INTEGRATION SERVER, an interface management; NEXUS/CLOUD IT, outsourcing solution; NEXUS/EPS, a software solution to supplement SAP personnel management, as well as process and HR consulting in the SAP environment; ifa systems, an ophthalmology software solution; Sophrona solutions, ophthalmology patients and referral program; and NEXUS/DIS, interdisciplinary diagnostic information system. Its information systems also comprise NEXUS/SWISSLAB, a laboratory information system; NEXUS/LAURIS for order communication in diagnostics; NEXUS/PATHOLOGY and NEXUS/CYTOLOGY for pathology and cytology institutes; dc-Pathos and dc-LabMan for pathology and cytology devices; NEXUS/RADIOLOGY, an information and image system for radiology wards and offices; NEXUs/CHILI, for PACS and teleradiology solutions; NEXUS/ASTRAIA for obstetrics and gynecology; NEXUS/SPECIAL DIAGNOSTICS and Clinic WinData for medical specialist diagnostics and device integration; NEXUS/HOME for senior citizen and nursing homes; NEXUS/OUTPATIENT CARE and Asebis, a homecare solution; NEXUS/PAT, an administration system for hospitals; and osoTEC for billing personal and other services. In addition, the company offers SINAPSI, highsystemNET, CREATIV OM, SEXTANT, Emed, NEXUS/EPD, NEXUS/AEMP, NEXUS/SPM, EuroSDS, RVS Software, NEXUS/VITA and TESIS VITA, and NEXUS/ESKULAP. NEXUS AG is headquartered in Donaueschingen, Germany.
Donaueschingen, 78166
:
ISIN: DE0005220909
: